title: Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.
abstract: To determine whether the multidrug resistance gene MDR1 could act as a selectable marker in human subjects, we studied engraftment of peripheral blood progenitor cells (PBPCs) transduced with either MDR1 or the bacterial NeoR gene in six breast cancer patients. This study differed from previous MDR1 gene therapy studies in that patients received only PBPCs incubated in retroviral supernatants (no nonmanipulated PBPCs were infused), transduction of PBPCs was supported with autologous bone marrow stroma without additional cytokines, and a control gene (NeoR) was used for comparison with MDR1. Transduced PBPCs were infused after high-dose alkylating agent therapy and before chemotherapy with MDR-substrate drugs. We found that hematopoietic reconstitution can occur using only PBPCs incubated ex vivo, that the MDR1 gene product may play a role in engraftment, and that chemotherapy may selectively expand MDR1 gene-transduced hematopoietic cells relative to NeoR transduced cells in some patients.
authors.affiliation: National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Moscow
authors.forename: H
authors.initials: H
authors.lastname: Huang
authors.forename: C
authors.initials: C
authors.lastname: Carter
authors.forename: K
authors.initials: K
authors.lastname: Hines
authors.forename: J
authors.initials: J
authors.lastname: Zujewski
authors.forename: G
authors.initials: G
authors.lastname: Cusack
authors.forename: C
authors.initials: C
authors.lastname: Chow
authors.forename: D
authors.initials: D
authors.lastname: Venzon
authors.forename: B
authors.initials: B
authors.lastname: Sorrentino
authors.forename: Y
authors.initials: Y
authors.lastname: Chiang
authors.forename: B
authors.initials: B
authors.lastname: Goldspiel
authors.forename: S
authors.initials: S
authors.lastname: Leitman
authors.forename: E J
authors.initials: EJ
authors.lastname: Read
authors.forename: A
authors.initials: A
authors.lastname: Abati
authors.forename: M M
authors.initials: MM
authors.lastname: Gottesman
authors.forename: I
authors.initials: I
authors.lastname: Pastan
authors.forename: S
authors.initials: S
authors.lastname: Sellers
authors.forename: C
authors.initials: C
authors.lastname: Dunbar
authors.forename: K H
authors.initials: KH
authors.lastname: Cowan
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D002454:Cell Differentiation / Q000235:genetics; D003131:Combined Modality Therapy; D005260:Female; D018014:Gene Transfer Techniques; D005798:Genes, Bacterial; D017930:Genes, Reporter; D015316:Genetic Therapy; D006085:Graft Survival; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000473:pathology / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D014182:Transplantation, Autologous
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1